Table 2.
Nanosystem | Target molecule/drug | Cell line/animals | Application | Result | References |
---|---|---|---|---|---|
Au@Ag core–shell nanoprobe | FA | MGC-803 cells | Surface-enhanced Raman scattering (SERS) activity | Nanoprobes exhibit excellent detection ability of living cancer cells | Chang et al. (2019b) |
Gold nanostar | Matrix metallopeptidase 2, IR-780 iodide | A549 cells | NIR imaging, PA imaging, PDT | Suppressed the growth of tumor, and the tumor volume decreased by 93% | Xia et al. (2019) |
AuNPs | Chlorotoxin (CTX), radionuclide 131I | BALB/c female nude mice | SPECT/computed tomography (CT) imaging, radionuclide therapy | Due to CTX, the developed nanoprobe can cross the Blood–Brain Barrier (BBB) and specifically target glioma cells in a rat intracranial glioma model | Zhao et al. (2019b) |
Au@Cu3 1,3,5-benzenetricarboxylate NPs | Aptamer, DOX | A549, BEAS-2B and HeLa cells | SERS imaging, chemo, and PT therapy | Nanosystem exhibited high drug loading capacity (57%). Effective in cell tracking and in vivo synergistic therapy | He et al. (2019) |
Magnetic AuNPs | DOX | MCF7 cells and Female Swiss mice | Contrast agent for MRI, chemo and PT therapy | Iron core allows the magnetic targeting of particles to tumor sites. Nanocomposite have the ability to visualize and kill tumor cells with high precision | Elbialy et al. (2019) |
AuNPs | PPP-CD-g-PEG | U87 and Vero cells | Fluorescence cell imaging and radiotherapy | Radiosensitivity efficiently increases with the use of this conjugate | Barlas et al. (2019) |
AuNPs/Gold sulphide (AuS) NPs | C225 (Cetuximab monoclonal antibody) | MDA MB 231 and A549 cells | PTT | PTT can reduce the cell survival to less than 20% | Ramezanzadeh et al. (2018) |
AuNPs | – | HSC-3 cells | – | Combination of 4 Gy irradiation with AuNPs significantly increases the apoptotic cells | Teraoka et al. (2018) |
PPP-CD-g-PEG poly(p-phenylene-co-cyclodextrin-g-poly(ethylene glycol)